| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |